Advertisement
Advertisement
U.S. Markets close in 1 hr 55 mins
Advertisement
Advertisement
Advertisement
Advertisement

Bellerophon Therapeutics, Inc. (BLPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0407-0.0693 (-6.24%)
As of 01:08PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/29/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.27
52-Week Change 3-72.66%
S&P500 52-Week Change 3-13.66%
52 Week High 34.4900
52 Week Low 30.6700
50-Day Moving Average 31.3291
200-Day Moving Average 31.7557

Share Statistics

Avg Vol (3 month) 325.87k
Avg Vol (10 day) 347.69k
Shares Outstanding 59.55M
Implied Shares Outstanding 6N/A
Float 87.31M
% Held by Insiders 13.52%
% Held by Institutions 131.76%
Shares Short (Aug 30, 2022) 423.03k
Short Ratio (Aug 30, 2022) 41.45
Short % of Float (Aug 30, 2022) 40.31%
Short % of Shares Outstanding (Aug 30, 2022) 40.24%
Shares Short (prior month Jul 28, 2022) 440.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 09, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb 09, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-48.51%
Return on Equity (ttm)-88.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.19M
Net Income Avi to Common (ttm)-18.65M
Diluted EPS (ttm)-1.8850
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.33M
Total Cash Per Share (mrq)1.71
Total Debt (mrq)586k
Total Debt/Equity (mrq)4.77
Current Ratio (mrq)3.12
Book Value Per Share (mrq)1.29

Cash Flow Statement

Operating Cash Flow (ttm)-17.97M
Levered Free Cash Flow (ttm)-12.68M
Advertisement
Advertisement